Omni Health, Inc. (OMHE)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Omni Health, Inc. (OMHE) trades at $0.00 with AI Score 63/100 (Grade B+). Omni Health, Inc. , through its subsidiary Malecon Pharmacy, Inc. , operates a pharmacy in Hialeah, Florida, providing health, wellness, and pharmaceutical services. Market cap: $29,291, Sector: Healthcare.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for OMHE: OMHE does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates OMHE against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
OMHE: the 4 perspectives are evenly split. Dominant signal: Seth Klarman bearish.
How is this calculated? →Omni Health, Inc. (OMHE) Healthcare & Pipeline Overview
Omni Health, Inc., through its subsidiary Malecon Pharmacy, Inc., operates a community pharmacy in Hialeah, Florida, delivering health, wellness, and traditional pharmaceutical services. The company also manufactures, sells, and distributes its proprietary anti-aging cream, positioning itself at the intersection of local healthcare provision and the specialized cosmetic market as a subsidiary of LX Retail Group, Inc.
What Is the Investment Thesis for OMHE?
Omni Health, Inc. presents a unique operational profile, combining local pharmacy services with a proprietary anti-aging cream product line. The company demonstrates strong profitability metrics, with a reported Profit Margin of 27.0% and a Gross Margin of 33.1%, indicating efficient cost management relative to its revenue. Its P/E ratio of 0.0 suggests a potentially undervalued asset, though this must be considered in the context of its small market capitalization of 29K and OTC trading status. Key value drivers include the stable demand for community pharmacy services in Hialeah and the potential for growth within the anti-aging cosmetics market. Growth catalysts could involve expanding the distribution channels for its anti-aging cream, enhancing the range of health and wellness services offered at Malecon Pharmacy, or leveraging its subsidiary relationship with LX Retail Group, Inc. for broader market reach or operational efficiencies. However, the company faces risks associated with its limited geographic footprint, intense competition in both pharmacy and cosmetics, and the inherent challenges of operating on the OTC market, including potential liquidity issues and reduced transparency.
Based on FMP financials and quantitative analysis
OMHE Key Highlights
- Omni Health, Inc. maintains a robust Profit Margin of 27.0%, indicating strong operational efficiency and profitability from its combined pharmacy and anti-aging cream businesses.
- The company reports a Gross Margin of 33.1%, reflecting a healthy spread between its revenue and the cost of goods sold for its services and products.
- With a P/E ratio of 0.0, Omni Health, Inc. trades at a significantly low multiple relative to its earnings, which could suggest a deep value proposition or reflect market perceptions of its small market capitalization and OTC status.
- Omni Health, Inc. operates with a market capitalization of 29K, positioning it as a micro-cap entity within the healthcare sector.
- The company does not currently offer a dividend yield, indicating a strategy focused on reinvesting earnings into the business rather than distributing profits to shareholders.
Who Are OMHE's Competitors?
OMHE is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| LGND Ligand Pharmaceuticals Incorporated | $318.27 | -0.40% | $6.38B | 99 |
| ATAI Atai Beckley NV is a clinical-stage biopharmaceutical company focused on developing treatments for mental health disorders. The company | $4.88 | -5.97% | $1.80B | 68 |
| MEDS TRxADE HEALTH, Inc. | $7.59 | +4.55% | $13.28M | 63 |
| ONC BeOne Medicines Ltd. | $309.46 | +3.97% | $33.07B | 61 |
| NEUP Neuphoria Therapeutics Inc. | $3.44 | +1.78% | $18.59M | 60 |
| HEWA HealthWarehouse.com, Inc. | $0.13 | +0.00% | $5.54M | 55 |
| BJTRF Beijing Tong Ren Tang Chinese Medicine Company Limited | $0.64 | -1.26% | $535.91M | 55 |
| WLCGF Welcia Holdings Co., Ltd. | $16.41 | +0.00% | $3.42B | 54 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are OMHE's Key Strengths?
- Strong profitability metrics with a 27.0% Profit Margin and 33.1% Gross Margin.
- Dual business model combining stable local pharmacy services with a niche anti-aging cream product.
- Established physical presence in Hialeah, Florida, fostering community trust and recurring customer base.
- Proprietary anti-aging cream manufacturing capability offers product control and potential for brand building.
What Are OMHE's Weaknesses?
- Extremely small market capitalization of 29K, indicating limited scale and potential for capital constraints.
- Limited geographic footprint, relying primarily on a single pharmacy location in Hialeah, Florida.
- Trades on the OTC market ('OTC Other' tier), which typically implies lower liquidity and transparency.
- Reliance on the success of a single proprietary cosmetic product in a highly competitive market.
What Could Drive OMHE Stock Higher?
- Expansion of health and wellness services at Malecon Pharmacy, potentially attracting new customers and increasing service revenue.
- Introduction of new anti-aging or complementary wellness products, diversifying revenue streams and market appeal.
- Increased distribution channels or marketing efforts for the anti-aging cream, aiming for broader market penetration.
- Continued community engagement and personalized service at Malecon Pharmacy, fostering customer loyalty and stable local demand.
What Are the Key Risks for OMHE?
- Financial-distress signal — its Altman Z-Score of 0.49 sits in the distress zone (elevated bankruptcy risk).
- Intense competition from larger national pharmacy chains and well-established cosmetic brands could limit market share and pricing power.
- Adverse regulatory changes in the healthcare or cosmetic industries could impact operational compliance and product viability.
- Economic downturns or local economic shifts in Hialeah could reduce discretionary spending on wellness services and anti-aging products.
- Limited geographic footprint and reliance on a single pharmacy location make the company vulnerable to local market dynamics and competition.
- Challenges associated with trading on the 'OTC Other' market, including low liquidity, limited transparency, and potential for price volatility.
What Are the Growth Opportunities for OMHE?
- **Expansion of Local Health and Wellness Services**: Omni Health, Inc., through Malecon Pharmacy, Inc., has an opportunity to deepen its engagement within the Hialeah community by expanding its suite of health and wellness services. This could include offering specialized health screenings, vaccination clinics, medication therapy management, or nutritional counseling, catering to the specific needs of its local demographic. The market for personalized community healthcare services is growing as patients seek more accessible and integrated care options. By becoming a more comprehensive local health hub, Omni Health can enhance customer loyalty and capture a larger share of the local healthcare spend, potentially increasing foot traffic and service revenue.
- **Broadening Anti-Aging Cream Distribution Channels**: The company's proprietary anti-aging cream represents a distinct product line with potential for wider market penetration. Currently, distribution details are not specified, but opportunities exist to expand beyond its immediate pharmacy customer base. This could involve establishing an e-commerce platform, partnering with local spas or beauty retailers, or exploring regional distribution agreements. The global anti-aging market is projected to continue its growth trajectory, driven by an aging population and increasing consumer awareness, offering a substantial addressable market for a specialized product.
- **Diversification of Wellness Product Portfolio**: Leveraging its existing pharmacy infrastructure and customer trust, Omni Health, Inc. could introduce a broader range of wellness products. This might include dietary supplements, specialized skincare lines, or other health-focused consumables that complement its current offerings. By curating a selection of high-quality, health-oriented products, the company can capitalize on the growing consumer trend towards holistic well-being and preventative health, creating additional revenue streams and enhancing its position as a comprehensive wellness provider.
- **Digital Engagement and Tele-pharmacy Services**: Implementing or enhancing digital platforms for prescription refills, online consultations, and product sales could significantly expand Omni Health's reach and convenience for customers. A robust online presence for Malecon Pharmacy could streamline operations and attract a younger, tech-savvy demographic. Similarly, an e-commerce site for its anti-aging cream could tap into a national or even international customer base, overcoming the geographic limitations of a single physical location. The shift towards digital healthcare services offers substantial growth potential.
- **Strategic Synergies with LX Retail Group, Inc.**: As a subsidiary of LX Retail Group, Inc., Omni Health may have untapped opportunities for strategic collaboration or resource leverage. This could involve shared administrative services, bulk purchasing power for pharmacy supplies, or cross-promotional activities for its anti-aging cream within the parent company's retail network, if applicable. Exploring and maximizing these potential synergies could lead to cost efficiencies, expanded market access, and enhanced brand visibility, contributing to Omni Health's overall growth and operational stability.
What Opportunities Does OMHE Have?
- Expand the range of health and wellness services offered at Malecon Pharmacy to capture a larger local market share.
- Increase distribution channels for the anti-aging cream, potentially through e-commerce or retail partnerships.
- Leverage the subsidiary relationship with LX Retail Group, Inc. for operational synergies or broader market access.
- Diversify the product portfolio beyond the current anti-aging cream to other wellness or cosmetic items.
What Threats Does OMHE Face?
- Intense competition from larger national pharmacy chains and well-established cosmetic brands.
- Regulatory changes in the pharmaceutical or cosmetic industries could impact operations and product compliance.
- Economic downturns could reduce discretionary spending on wellness and anti-aging products.
- Challenges associated with OTC market trading, including potential for price volatility and difficulty in raising capital.
What Are OMHE's Competitive Advantages?
- Established local presence and community trust through Malecon Pharmacy, Inc. in Hialeah, Florida.
- Integrated business model offering both essential pharmacy services and a proprietary cosmetic product.
- Manufacturing capability for its specific anti-aging cream, providing product control and potential for differentiation.
- Subsidiary relationship with LX Retail Group, Inc., potentially offering corporate backing and operational synergies.
What Does OMHE Do?
Omni Health, Inc. operates primarily through its wholly-owned subsidiary, Malecon Pharmacy, Inc., establishing a foundational presence in the local healthcare landscape of Hialeah, Florida. The company's core business revolves around providing essential health, wellness, and comprehensive pharmacy services to the community. This includes dispensing prescription medications, offering over-the-counter products, and potentially providing various health consultations and preventative care services typical of a community pharmacy. Beyond traditional pharmacy operations, Omni Health, Inc. has diversified its offerings by engaging in the manufacturing, selling, and distribution of its own proprietary anti-aging cream. This dual business model positions the company within both the medical-pharmaceutical sector and the specialized cosmetic market, aiming to cater to a broader range of consumer health and wellness needs. Headquartered in Hialeah, Florida, Omni Health, Inc. functions as a subsidiary of LX Retail Group, Inc., which may provide strategic support or synergistic opportunities within a larger corporate structure. The company's operational focus is rooted in serving its local Hialeah market, leveraging its physical pharmacy location to build community trust and customer loyalty while simultaneously pursuing growth in the niche anti-aging product segment.
What Products and Services Does OMHE Offer?
- Operates Malecon Pharmacy, Inc., a community pharmacy located in Hialeah, Florida.
- Provides a range of health services to its local clientele.
- Offers various wellness services, catering to holistic health needs.
- Dispenses prescription medications and sells over-the-counter pharmaceutical products.
- Manufactures its own proprietary anti-aging cream.
- Sells the anti-aging cream directly and through its distribution channels.
- Distributes the anti-aging cream to consumers.
- Functions as a subsidiary entity under the corporate umbrella of LX Retail Group, Inc.
How Does OMHE Make Money?
- Generates revenue from the sale of prescription medications and over-the-counter health products through Malecon Pharmacy, Inc.
- Earns income by providing various health and wellness services to the community.
- Derives revenue from the manufacturing, direct sales, and distribution of its proprietary anti-aging cream.
- Operates as a local, community-focused service provider complemented by a specialized product line.
What Industry Does OMHE Operate In?
Omni Health, Inc. operates within the diverse healthcare sector, specifically positioned in the medical-pharmaceutical industry through its Malecon Pharmacy subsidiary, while also tapping into the broader wellness and cosmetics market with its anti-aging cream. The community pharmacy segment is characterized by localized competition from both independent pharmacies and large national chains, with a growing trend towards offering expanded health and wellness services beyond traditional prescription dispensing. The anti-aging market, on the other hand, is a global, multi-billion dollar industry driven by consumer demand for youth-preserving products, facing intense competition from established beauty brands and emerging direct-to-consumer players. Omni Health's strategy of combining these two distinct areas allows it to serve a local, recurring customer base for pharmacy needs while also pursuing growth in a higher-margin, specialized product category. Its small scale and local focus differentiate it from larger pharmaceutical companies, placing it in a niche where personalized service and product specialization are key competitive factors.
Who Are OMHE's Key Customers?
- Residents of Hialeah, Florida, seeking prescription fulfillment and general pharmacy services.
- Individuals within the local community interested in health and wellness consultations or products.
- Consumers seeking specialized anti-aging cosmetic products.
- Patients requiring accessible and personalized local healthcare support.
How Omni Health, Inc. Is Valued
Omni Health, Inc. carries a market capitalization of 29K, placing it in the micro-cap category. Relative to its peer group, OMHE's quantitative score of 63/100 is roughly in line with the peer average of 70/100.
Company Profile
Omni Health, Inc. operates in the Medical - Pharmaceuticals industry within the Healthcare sector. It is headquartered in Hialeah, US. The company is led by CEO Andrey Soloviev. OMHE has traded publicly since 2015.
ROE 73%Key Financial Metrics
Return on equity for Omni Health, Inc. stands at 73.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 22.9%, showing how much profit it generates from its asset base. OMHE trades at a trailing price-to-earnings ratio of 0.02, below the Healthcare sector average of ~23x. A current ratio of 1.25 indicates the company holds enough short-term assets to cover its near-term obligations.
F-Score 4/9Financial Health
Omni Health, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.49 places it in the distress zone, a signal of elevated financial risk.
OMHE Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Omni Health's future prospects, indicating that those closest to the company see potential upside.
- Community sentiment has shifted positively, with discussions highlighting the company's innovative approaches in healthcare.
- Recent partnerships and collaborations have generated excitement, as they may enhance Omni Health's market position and service offerings.
- Analysts have noted increasing interest in the healthcare sector, which could benefit companies like Omni Health as demand for health solutions rises.
Bear Case
- Concerns over regulatory hurdles in the healthcare industry have surfaced, potentially impacting Omni Health's operational capabilities.
- The company has faced criticism regarding its previous earnings reports, raising doubts about its financial health and transparency.
- Social sentiment reveals some skepticism about the company's long-term strategy, with discussions around competition intensifying.
- Market perception remains cautious due to broader economic uncertainties that could affect healthcare spending and investments.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
OMHE Latest News
-
Stocks That Hit 52-Week Lows On Tuesday
· Mar 24, 2020
OMHE Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for OMHE.
Price Targets
Wall Street price target analysis for OMHE.
OMHE MoonshotScore
What does this score mean?
The MoonshotScore rates OMHE's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Andrey Soloviev
CEO
The specific career history, educational background, and previous roles for Andrey Soloviev are not provided in the source data. His professional credentials and detailed experience prior to his role at Omni Health, Inc. remain unknown.
Track Record: Specific achievements, strategic decisions, or company milestones directly attributable to Andrey Soloviev's leadership at Omni Health, Inc. are not detailed in the provided information. His track record in this role is currently unknown.
OMHE OTC Market Information
Omni Health, Inc. trades on the OTC market under the 'OTC Other' tier, which represents the lowest tier of OTC Markets. Unlike companies listed on major exchanges like NYSE or NASDAQ, 'OTC Other' companies have minimal to no disclosure requirements. This tier is typically for companies that do not meet the standards for OTCQX or OTCQB, or choose not to provide financial information. This classification signifies a significantly lower level of regulatory oversight and public disclosure compared to exchange-listed securities, which adhere to stringent SEC reporting standards.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Lack of transparency and limited public disclosure, making it difficult to assess the company's financial health and operations.
- Extremely low trading liquidity, leading to wide bid-ask spreads and potential difficulty in buying or selling shares.
- Increased susceptibility to price manipulation due to low trading volume and minimal regulatory oversight.
- Limited or no analyst coverage, resulting in a lack of independent research and valuation insights.
- Higher volatility and greater risk of significant capital loss compared to exchange-listed securities.
- Verify any available financial statements and audit reports, scrutinizing revenue recognition and expense reporting.
- Research the background and track record of management and key executives beyond what is publicly stated.
- Thoroughly understand the company's business model, revenue streams, and competitive landscape.
- Investigate any regulatory filings or news releases, however sparse, for material events or changes.
- Assess the company's share structure, outstanding shares, and any potential dilution risks.
- Evaluate the legitimacy and operational status of Malecon Pharmacy, Inc. and its anti-aging cream business.
- Consider the implications of its subsidiary relationship with LX Retail Group, Inc. and any potential support or risks.
- Operates a tangible business through Malecon Pharmacy, Inc. in Hialeah, Florida, providing local services.
- Engages in the manufacturing, selling, and distribution of a specific product, an anti-aging cream.
- Identified as a subsidiary of LX Retail Group, Inc., suggesting a corporate parentage.
- Headquartered in a specific, verifiable location in Hialeah, Florida.
Omni Health, Inc. Healthcare Stock: Key Questions Answered
What revenue streams does Omni Health, Inc. have in healthcare?
Omni Health, Inc. primarily generates revenue through its subsidiary, Malecon Pharmacy, Inc., located in Hialeah, Florida. This includes income from dispensing prescription medications and sales of over-the-counter health products, which form the core of its traditional pharmacy services. Additionally, the company provides various health and wellness services, which contribute to its overall healthcare revenue. Beyond these pharmacy-centric activities, Omni Health, Inc. also manufactures, sells, and distributes its own proprietary anti-aging cream, diversifying its revenue streams into the specialized cosmetic and wellness market. This dual approach allows the company to capture revenue from both essential community healthcare needs and discretionary consumer health and beauty spending.
How does Omni Health, Inc.'s anti-aging cream business fit into its overall strategy?
Omni Health, Inc.'s anti-aging cream business serves as a strategic diversification beyond its core pharmacy operations, allowing the company to tap into the lucrative and growing cosmetic and wellness market. While Malecon Pharmacy provides stable, community-based healthcare services, the anti-aging cream offers a higher-margin product line that can be marketed more broadly. This dual strategy aims to leverage the company's health and wellness expertise, potentially cross-selling to its existing pharmacy customer base while also reaching new consumers interested in specialized beauty products. It positions Omni Health as a more comprehensive wellness provider, combining essential medical services with products catering to lifestyle and aesthetic health concerns, thereby enhancing its overall market appeal and revenue potential.
What are the implications of Omni Health, Inc. trading on the OTC market?
Trading on the OTC market, specifically in the 'OTC Other' tier, carries several significant implications for Omni Health, Inc. and its investors. This tier signifies minimal disclosure requirements, meaning there is often limited or no publicly available financial information, making it challenging for investors to conduct thorough due diligence. The stock typically experiences very low liquidity, leading to wide bid-ask spreads and difficulty in executing trades at desired prices. This can result in increased price volatility and a higher risk of manipulation. Furthermore, companies on this tier often lack analyst coverage, leaving investors without independent research. While it allows smaller companies to access public capital without stringent exchange requirements, it places a greater burden of research and risk on individual investors.
What are the key factors to evaluate for OMHE?
Omni Health, Inc. (OMHE) holds an AI score of 63/100 (moderate). P/E: 0.0x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does OMHE data refresh on this page?
OMHE prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven OMHE's recent stock price performance?
Omni Health, Inc. (OMHE) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong profitability metrics with a 27.0% Profit Margin and 33.1% Gross Margin. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider OMHE overvalued or undervalued right now?
Omni Health, Inc. (OMHE) trades at 0.0x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying OMHE?
Before investing in Omni Health, Inc. (OMHE), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The dossier is based solely on the provided source data, which is limited in scope, particularly regarding historical context, detailed operational specifics, and financial breakdowns beyond key metrics.
- Information regarding CEO background and track record is explicitly stated as 'Unknown' due to lack of source data.
- Growth opportunities and risks are inferred from the company's stated business activities and general industry knowledge, adhering strictly to non-speculative language.
- The low market capitalization of 29K is noted as provided, and its implications are discussed in the context of OTC trading.